Search Results for "Paediatric Study Teriflunomide"

15:38 EDT 25th October 2014 | BioPortfolio

Original Source: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

The primary objective is to demonstrate that early intervention with Teriflunomide in patients presenting with their first clinical episode consistent with MS prevents or delays conversion to clinically definite Multiple Sclerosis [MS]. The secondary objectives are: - to demonstrate that Teriflunomide prevents or delays conversion to MS based on the revised McDonald Criteria and delays disability progression, - to evaluate the long-term safety of Teriflunom...

Matching Channels

SERAPHIN study

SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Viruses

A virus is a small infectious agent that can replicate only inside the living cells of organisms. Virus particles (known as virions) consist of two or three parts: the genetic material made from eit...

Testicular Cancer

Testicular cancer represents only 1 per cent of all cancers in men, but it is the single biggest cause of cancer-related deaths in men aged 15-35 years in the UK. The causes of testicular cancer and...

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Matching News

[Articles] Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

TOPIC is to our knowledge the first study to report benefits of an available oral disease-modifying therapy in patients with early multiple sclerosis. These results extend the stages of multiple scler...

Mundipharma announces results of pivotal phase III study for flutiform® in paediatric asthma

New data from a randomised, multicentre, phase III study, being presented at the European Respiratory Society (ERS) annual congress in Munich, Germany, supports the potential of flutiform® for the tr...

Ferrer initiates second phase III clinical study for Ozenoxacin in adult and paediatric patients with impetigo

Ferrer announced that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatr...

New European roadmap established to tackle paediatric cancer

Around 160 paediatric oncology stakeholders from 31 countries have committed to a strategic undertaking with life-enhancing potential: a long-term European Paediatric Cancer Plan for better care and r...

BRIEF-Tigenix says EMA accepts Paediatric Investigation Plan for Cx601

* The paediatric committee of EMA issued positive opinion on co's paediatric investigation plan for Cx601, a locally injected stem cell product in Phase III of clinical development for the treatment o...

News and press releases: European Medicines Agency publishes first public summaries of Paediatric Committee evaluations of paediatric investigation plans

The European Medicines Agency has published the first summaries for the public of the Paediatric Committee's (PDCO) evaluations of paediatric investigation plans (PIP) and waiver applications.

GSK announces results of Phase III PETIT2 study of eltrombopag (Promacta™/Revolade™) in paediatric patients with chronic immune thrombocytopenia

GlaxoSmithKline (GSK) plc today announced the results from the Phase III PETIT2 study evaluating the efficacy of eltrombopag vs. placebo in paediatric patients with chronic immune (idiopathic) thrombo...

Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee—adolescents’ melanoma as a paradigm

The European Medicines Agency (EMA) website lists all diseases that officially exist in adults only. The class waiver for juvenile melanoma was revoked in 2008 referring to US SEER statistics. This st...

Matching PubMed Articles

Continuing education case study quiz.

Goal- The goal of this program is to educate pharmacists about the use of teriflunomide for the treatment of multiple sclerosis (MS). Objectives- At the completion of this program, the reader will be ...

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.

A number of novel oral agents are now approved for use in relapsing multiple sclerosis (MS). Among these agents, teriflunomide has shown promise with respect to clinical efficacy and safety in relapsi...

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis.

Treatment of multiple sclerosis (MS) is challenging: disease-modifying treatments (DMTs) must both limit unwanted immune responses associated with disease initiation and propagation (as T and B lympho...

Oral Medicines for Children in the European Paediatric Investigation Plans.

Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric d...

What does general paediatric surgery involve? An audit of paediatric cases in 1 year.

As all tertiary paediatric hospitals are based in the capital of Dublin, it is therefore necessary for general surgeons in centres outside of Dublin to undertake routine elective and emergency paediat...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement